Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cyclooxygenase inhibitors derived from thalidomide.

Mamiko Suizu1, Yohei Muroya, Hiroki Kakuta

  • 1Institute of Molecular & Cellular Biosciences, The University of Tokyo, Japan.

Chemical & Pharmaceutical Bulletin
|September 3, 2003
PubMed
Summary

New N-3,5-dimethylphenylphthalimide analogs show stronger cyclooxygenase inhibition than aspirin. Structural modifications were explored to enhance this anti-inflammatory activity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inhibitory effect of the water-soluble retinoid X receptor partial agonist CAt-PMN on allergic conjunctivitis-like responses in mice.

Experimental eye research·2026
Same author

Red-Light-Driven Giese Reaction Catalyzed by Zinc(II)porphyrin.

The Journal of organic chemistry·2026
Same author

Cooperative Chiral Induction in Aromatic <i>N</i>,<i>N</i>'-Dialkylated Urea Organocatalyst Enables Asymmetric Aza-Henry Reaction.

The Journal of organic chemistry·2026
Same author

A novel selective stabilizer of the ryanodine receptor 2 prevents stress-induced ventricular arrhythmias without impairing cardiac function.

British journal of pharmacology·2026
Same author

Rexinoid NEt-3IB Promotes Resident Macrophage Gene Expression and Mitigates Desiccation-Induced Ocular Surface Disease.

Investigative ophthalmology & visual science·2026
Same author

Aromatic Amide Foldamers Show Conformation-Dependent Electronic Properties.

Chemphyschem : a European journal of chemical physics and physical chemistry·2025

Area of Science:

  • Medicinal Chemistry
  • Pharmacology

Background:

  • Cyclooxygenase (COX) enzymes are key targets for anti-inflammatory drugs.
  • Thalidomide analogs have been explored for various therapeutic applications.
  • Aspirin is a widely used non-steroidal anti-inflammatory drug (NSAID) with COX-inhibiting properties.

Purpose of the Study:

  • To synthesize and evaluate novel N-3,5-dimethylphenylphthalimide analogs.
  • To investigate the structure-activity relationships of these compounds concerning cyclooxygenase inhibition.
  • To identify analogs with superior COX-inhibiting potency compared to aspirin.

Main Methods:

  • Systematic structural modification of a thalidomide-based scaffold.
  • Synthesis of N-3,5-dimethylphenylphthalimide analogs.

Related Experiment Videos

  • In vitro assays to measure cyclooxygenase inhibition activity.

    • Main Results:

    • Several synthesized analogs demonstrated potent cyclooxygenase-inhibiting activity.
    • The potency of these analogs exceeded that of aspirin.
    • Specific substituent effects on the phenylphthalimide core were correlated with activity levels.

    Conclusions:

    • N-3,5-dimethylphenylphthalimide derivatives represent a promising class of compounds for developing novel anti-inflammatory agents.
    • Structural optimization can yield analogs with significantly enhanced cyclooxygenase inhibition.
    • These findings provide a basis for further development of potent COX inhibitors.